Teranode Improves Lab Flexibility and Efficiency with Launch of New Screening Automation Solution
Teranode Corporation, the leading innovator of experiment design automation (XDA) software for the Life Sciences industry, today announced the availability of TERANODE™ Screening Automation, a complete informatics solution for screening laboratories with changing or emerging assay requirements. TERANODE Screening Automation provides easy-to-deploy assay automation with flexible assay design and real-time analytics. Leveraging TERANODE XDA, the solution makes it seamless for screening managers to maintain flexible operations and cost-effectively automate screens. (See also today’s press release entitled, “Teranode Launches Industry’s First Model-Driven LIMS for the Life Sciences.”)
“An informatics solution needs to allow lab personnel to focus on the science, not the database,” says Edward Hyde, Technical Director, Center for Neurodegenerative Disease Research, University of Pennsylvania. “Assay automation that can be changed, on demand, by laboratory users to match ever-changing data requirements enables responsiveness and continuous improvement.”
Today’s R&D projects are driving an ever-increasing level of genetic, biological, and chemical screening activity in the Life Sciences industry. As organizations strive to expand drug pipelines and shorten drug development times, the demand to more accurately understand drug actions and biological mechanisms through advanced screening approaches are intensifying. TERANODE Screening Automation enables screening groups to leverage model-driven informatics to address the challenge of constantly changing data requirements, while decreasing operating costs.
TERANODE Screening Automation
TERANODE Screening Automation is an easy-to-deploy, cost-effective solution for the screening laboratory. Key features include:
• Assay Design Templates
TERANODE Screening Automation includes template designs for screening that include combinatorial reformatting examples, inventory interfaces, library definitions, curve- fitting, and reporting.
• TERANODE Design Suite
The full power of TERANODE Design Suite includes Protocol Modeler to visually modify assay designs, Protocol Player to provide assay automation and real-time analytics, and Biological Modeler for pathway analysis.
• TERANODE Model Server
A common repository for searching, reporting, and collaboration is provided through the TERANODE Model Server.
• Integration Library
A library of existing equipment interfaces provides configurable data interfaces to most lab equipment.
“Rapid target identification and characterization of drug activity can accelerate R&D projects,” said Neil Fanger, Ph.D, Industry Development Leader for Teranode. “TERANODE Screening Automation accelerates screening results by enabling labs to be more flexible and efficient in the face of changing research demands.”
To learn more about getting the most out of screening automation for the Life Sciences, please see Teranode’s “Maximizing Screening Automation for Life Sciences R&D” white paper at:
http://www.teranode.com/solutions/screening_automation.php
Pricing and Availability
TERANODE Screening Automation includes software and services for installation, design, and training. Pricing begins at $50,000 and is available immediately for purchase. For additional pricing information, please email Teranode sales at sales@teranode.com .
About Teranode Corporation
Teranode Corporation, headquartered in Seattle, WA, is the leading innovator of experiment design automation (XDA) software to improve speed and quality of experimentation for the benefit of accelerated R&D. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington. TERANODE XDA is being used by leading pharmaceutical, biotechnology, research, and academic organizations including Pfizer, AstraZeneca, and Fred Hutchinson Cancer Research Center. www.teranode.com
